Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
The company announced the U.S. rollout at the American Hernia Society’s 16 th Annual Hernia Repair meeting, taking place in Las Vegas, Nevada from March 13 through March 15.In addition to Symbotex composite mesh, Covidien is showcasing the latest innovations to its portfolio of hernia repair products, including AccuMesh™ positioning system and ProGrip™ laparoscopic self-fixating mesh. For more information, please visit AHS Booth #500/502. Symbotex composite mesh received 510(k) clearance from the U.S. Food and Drug Administration in August 2013. ABOUT COVIDIEN Covidien is a leading global health care products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien develops, manufactures and sells a diverse range of industry-leading medical device and supply products. With 2013 revenue of $10.2 billion, Covidien has more than 38,000 employees worldwide in more than 70 countries, and its products are sold in over 150 countries. Please visit www.covidien.com to learn more about our business.